Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenACYW concomitant pediatric vaccine immunogenicity and safety study in infants and toddlers
2017-004731-36Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3 trial of Meningococcal ACWY conjugate vaccine in meningococcal disease (2 arms), sponsored by Sanofi. Primary endpoint: Antibody titers against meningococcal serogroups A, C, Y, and W. Started Aug 2018; status: completed.
02
Drugs
Meningococcal ACWY conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2017-004731-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004731-36.